Add BrightSurf on Google Email

BU study finds HIV-1 proviruses may drive chronic systemic inflammation

08.10.26 | Boston University School of Medicine
SAMSUNG T9 Portable SSD 2TB

SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.

(Boston)—HIV (human immunodeficiency virus) is a virus that attacks the body's immune system,” and remains a major global health challenge due to persistent viral reservoirs, despite effective treatments. Key factors include around 40 million people living with HIV, a million new infections each year and permanent viral DNA integration into host cells. Some HIV proviruses hide quietly in cells and escape both medicines and the immune system, creating a permanent viral reservoir that stops patients from being cured.

People living with HIV are at higher risk of developing inflammatory diseases of many tissues, including the brain, heart, intestine and immune tissues, even when receiving antiviral treatments that control HIV expression and spread. A new study from researchers at Boston University Chobanian & Avedisian School of Medicine suggests that persistent hidden HIV contributes to this inflammation.

“People with HIV-1 are at higher risk of developing age-associated comorbidities and immune exhaustion even when receiving antiviral treatments and having no detectable virus present in the blood. Our results highlight the importance of the persistent defective HIV-1 proviruses and understanding their impact on driving chronic inflammation to inform future strategies to assure people with HIV-1 healthy living and aging,” explains corresponding author Andrew Henderson, PhD, professor of medicine and virology, immunology & microbiology.

For this study, the researchers infected cells and generated cells that had defective viruses using the editing tool CRISPR (clustered regularly interspaced short palindromic repeats) or molecular scissors, so they would not normally express HIV. They then compared those cells with HIV and defective HIV and measured markers of inflammation. An increase in inflammation markers was observed in the cells with the modified viruses.

According to the researchers, these findings could have implications for the persistent inflammation observed in people with HIV, especially with this population living longer. “It may also provide some general mechanisms that contribute to persistent inflammation associated with autoimmunity or aging.”

The researchers believe the study also provides additional insights into how HIV leads to general immune dysfunction and has potential implications about HIV cure strategies and targeting the persistent HIV reservoir.

These findings appear online in the Journal of Virology .

This project was funded in part by Boston University's Undergraduate Research Opportunities Program to AD, National Institutes of Health grant R35GM128625 to JFB, and National Institutes of Health grants R01 AI187175 and DA055488 to AJH & SG.

Journal of Virology

10.1128/jvi.00552-26

Experimental study

Cells

Intragenic transcription from defective HIV proviruses triggers interferon responses in myeloid cells

10-Aug-2026

Keywords

Article Information

Contact Information

Gina DiGravio
Boston University School of Medicine
ginad@bu.edu

How to Cite This Article

APA:
Boston University School of Medicine. (2026, August 10). BU study finds HIV-1 proviruses may drive chronic systemic inflammation. Brightsurf News. https://www.brightsurf.com/news/LMJRO34L/bu-study-finds-hiv-1-proviruses-may-drive-chronic-systemic-inflammation.html
MLA:
"BU study finds HIV-1 proviruses may drive chronic systemic inflammation." Brightsurf News, Aug. 10 2026, https://www.brightsurf.com/news/LMJRO34L/bu-study-finds-hiv-1-proviruses-may-drive-chronic-systemic-inflammation.html.